Clinical Trial Update: Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating axicabtagene ciloleucel given with steroids in relapsed or refractory diffuse large B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Axicabtagene ciloleucel (axicabtagene ciloleucel)

Snippet

Sponsor: Kite, A Gilead Company | Conditions: Relapsed or Refractory Large B-cell Lymphoma | Phase 2 | Status: COMPLETED